China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)
China
· Delayed Price · Currency is CNY 18.92
+0.13 (0.69%)
May 13, 2025, 3:00 PM CST
SHA:600062 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 11,053 | 11,119 | 11,177 | 9,522 | 9,034 | 8,391 | Upgrade
|
| Other Revenue | 92.76 | 92.76 | 133.12 | 102.99 | 77.88 | 112.69 | Upgrade
|
| Revenue | 11,145 | 11,212 | 11,310 | 9,625 | 9,112 | 8,504 | Upgrade
|
| Revenue Growth (YoY) | -4.59% | -0.87% | 17.50% | 5.64% | 7.14% | -9.35% | Upgrade
|
| Cost of Revenue | 4,738 | 4,832 | 4,904 | 4,307 | 4,048 | 3,157 | Upgrade
|
| Gross Profit | 6,408 | 6,380 | 6,406 | 5,318 | 5,064 | 5,347 | Upgrade
|
| Selling, General & Admin | 4,128 | 4,127 | 3,937 | 3,478 | 3,502 | 3,764 | Upgrade
|
| Research & Development | 515.31 | 555.19 | 627.85 | 482.48 | 409.59 | 291.02 | Upgrade
|
| Other Operating Expenses | 61.51 | 75.98 | 106.24 | 119.35 | 115.75 | 114.41 | Upgrade
|
| Operating Expenses | 4,686 | 4,739 | 4,681 | 4,081 | 4,029 | 4,173 | Upgrade
|
| Operating Income | 1,722 | 1,641 | 1,725 | 1,237 | 1,034 | 1,173 | Upgrade
|
| Interest Expense | -15.36 | -15.36 | -15.4 | -10.62 | -11.62 | -3.66 | Upgrade
|
| Interest & Investment Income | 198.56 | 198.56 | 190.56 | 89.68 | 81.55 | 51.33 | Upgrade
|
| Earnings From Equity Investments | -16.03 | - | - | 16.23 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 9.19 | 9.19 | 6.6 | 18.06 | -4.97 | -0.48 | Upgrade
|
| Other Non Operating Income (Expenses) | -26.91 | -2.32 | 61.3 | 6.36 | 0.26 | -10.33 | Upgrade
|
| EBT Excluding Unusual Items | 1,871 | 1,831 | 1,968 | 1,357 | 1,099 | 1,210 | Upgrade
|
| Impairment of Goodwill | -29.41 | -29.41 | -28.9 | - | -56.68 | -43.42 | Upgrade
|
| Gain (Loss) on Sale of Investments | -1.64 | -1.64 | 13.7 | 5.99 | 35.36 | 29.05 | Upgrade
|
| Gain (Loss) on Sale of Assets | 46.59 | 46.84 | 0.18 | -2.27 | 1.03 | -22.52 | Upgrade
|
| Asset Writedown | -62.79 | -59.17 | -57.52 | -8.43 | -0.54 | -0.12 | Upgrade
|
| Other Unusual Items | 78.87 | 78.87 | 40.85 | 82.76 | 42.65 | 41.92 | Upgrade
|
| Pretax Income | 1,903 | 1,867 | 1,937 | 1,435 | 1,121 | 1,215 | Upgrade
|
| Income Tax Expense | 231.23 | 215.94 | 272.71 | 201.27 | 149.06 | 201.52 | Upgrade
|
| Earnings From Continuing Operations | 1,671 | 1,651 | 1,664 | 1,234 | 972.13 | 1,013 | Upgrade
|
| Minority Interest in Earnings | -50.2 | -23.02 | 6.29 | -53.59 | -36.45 | -8.33 | Upgrade
|
| Net Income | 1,621 | 1,628 | 1,670 | 1,180 | 935.69 | 1,005 | Upgrade
|
| Net Income to Common | 1,621 | 1,628 | 1,670 | 1,180 | 935.69 | 1,005 | Upgrade
|
| Net Income Growth | -10.36% | -2.55% | 41.55% | 26.12% | -6.91% | -4.74% | Upgrade
|
| Shares Outstanding (Basic) | 1,029 | 1,028 | 1,024 | 1,036 | 1,043 | 1,043 | Upgrade
|
| Shares Outstanding (Diluted) | 1,029 | 1,028 | 1,024 | 1,036 | 1,043 | 1,043 | Upgrade
|
| Shares Change (YoY) | 0.48% | 0.33% | -1.07% | -0.74% | - | 0.00% | Upgrade
|
| EPS (Basic) | 1.58 | 1.58 | 1.63 | 1.14 | 0.90 | 0.96 | Upgrade
|
| EPS (Diluted) | 1.58 | 1.58 | 1.63 | 1.14 | 0.90 | 0.96 | Upgrade
|
| EPS Growth | -10.79% | -2.87% | 43.09% | 27.06% | -6.91% | -4.74% | Upgrade
|
| Free Cash Flow | 1,102 | 1,188 | 1,245 | 889.57 | 849.25 | 1,012 | Upgrade
|
| Free Cash Flow Per Share | 1.07 | 1.16 | 1.22 | 0.86 | 0.81 | 0.97 | Upgrade
|
| Dividend Per Share | 0.471 | 0.471 | 0.257 | 0.578 | 0.480 | 0.290 | Upgrade
|
| Dividend Growth | 83.27% | 83.27% | -55.54% | 20.42% | 65.52% | -4.61% | Upgrade
|
| Gross Margin | 57.49% | 56.91% | 56.64% | 55.25% | 55.57% | 62.87% | Upgrade
|
| Operating Margin | 15.45% | 14.64% | 15.26% | 12.85% | 11.35% | 13.80% | Upgrade
|
| Profit Margin | 14.55% | 14.52% | 14.77% | 12.26% | 10.27% | 11.82% | Upgrade
|
| Free Cash Flow Margin | 9.88% | 10.59% | 11.01% | 9.24% | 9.32% | 11.90% | Upgrade
|
| EBITDA | 2,452 | 2,358 | 2,390 | 1,778 | 1,482 | 1,548 | Upgrade
|
| EBITDA Margin | 22.00% | 21.03% | 21.13% | 18.47% | 16.26% | 18.20% | Upgrade
|
| D&A For EBITDA | 730.2 | 717.07 | 664.52 | 540.36 | 447.4 | 374.36 | Upgrade
|
| EBIT | 1,722 | 1,641 | 1,725 | 1,237 | 1,034 | 1,173 | Upgrade
|
| EBIT Margin | 15.45% | 14.64% | 15.26% | 12.85% | 11.35% | 13.80% | Upgrade
|
| Effective Tax Rate | 12.15% | 11.57% | 14.08% | 14.03% | 13.30% | 16.59% | Upgrade
|
| Revenue as Reported | 11,212 | 11,212 | 11,310 | 9,625 | 9,112 | 8,504 | Upgrade
|
| Advertising Expenses | - | 85.96 | 35.82 | - | - | 45.64 | Upgrade
|
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.